This piece covers the fascinating upside to the recent global pandemic we have been facing in medicine; increased application of innovation and better time efficiency.

"We have learned that we can move very quickly"

How have innovations in times of crisis meant that technology has been able to be used which has 'upscaled' remote patient monitoring? How has the value of this innovation become clear during this recent resource stretched period?

"People reached out for innovation, why would we go back?"

This piece focuses on opioid toxicity, nociception monitoring and pain management.

To learn more about NOL® technology and the clinical evidence on the benefits of nociception monitoring please visit: www.medasense.com

Presented by Desiree Chappell and Monty Mythen with their guests Frank Chan, Vice President & General Manager, Patient Monitoring at Medtronic, Jason Case, Vice President, R&D, Patient Monitoring at Medtronic and Michelle Jones, Senior Director, Global Marketing, Patient Monitoring and Minimally Invasive Therapies, Medtronic.